The page cannot be displayed because you are using Internet Explorer version 8 or lower.

Please consider upgrading your browser here

We use cookies on this website. By using the website you accept our use of cookies. Accept

 
 
 
 

2006 - Mads Øvlisen retires

Mads Øvlisen, who plays a key role in the Foundation’s recent history, retires both from the Board of the Novo Nordisk Foundation and as Chair of the Board of Novo Nordisk A/S.

Close